Science Times Observer
SEE OTHER BRANDS

Your top news on science and technology

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on May 8, 2025

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date   CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal …

Sprout Social Announces First Quarter 2025 Financial Results

Sprout Social Announces First Quarter 2025 Financial Results

CHICAGO, May 08, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced financial results for its first quarter ended March …

Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

Pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel in HLHS, a rare pediatric disease and orphan-designated indication, has reached approximately 95% enrollment and is expected to complete enrollment in the second quarter of 2025 …

Magnite to Participate in Upcoming Financial Conferences

Magnite to Participate in Upcoming Financial Conferences

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host in-person investor meetings at the following financial …

CarGurus Announces First Quarter 2025 Results

CarGurus Announces First Quarter 2025 Results

Marketplace revenue grew 13% YoY Q1'25 Net Income of $39.0 million; Non-GAAP Adjusted EBITDA of $66.3 million, up 32% YoY Repurchased $184.2 million worth of shares in Q1'25, representing 6% of our outstanding capital BOSTON, May 08, 2025 (GLOBE NEWSWIRE) …

Bridger Aerospace Announces Record First Quarter; Reiterates 2025 Guidance

Bridger Aerospace Announces Record First Quarter; Reiterates 2025 Guidance

BELGRADE, Mont., May 08, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported record results for …

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Encouraging results of Cohort A data from the ASCEND trial presented at ASCO-GI 2025; Cohort B results from the ASCEND trial accepted for an oral presentation at ESMO-GI 2025 Cash runway extending into the third quarter of 2026 with no debt Conference call …

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

CANTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical …

Varonis to Present at Upcoming Investor Conferences

Varonis to Present at Upcoming Investor Conferences

MIAMI, May 08, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced its participation at the following upcoming conferences: The J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference …

Senseonics Holdings, Inc. Reports First Quarter Financial Results

Senseonics Holdings, Inc. Reports First Quarter Financial Results

Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 …

Titan Machinery Inc. to Report Fiscal First Quarter Ended April 30, 2025 Results on Thursday, May 22, 2025

Titan Machinery Inc. to Report Fiscal First Quarter Ended April 30, 2025 Results on Thursday, May 22, 2025

WEST FARGO, N.D., May 08, 2025 (GLOBE NEWSWIRE) -- Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, announced today it will release financial results for the first quarter April 30, 2025 …

SUNation Energy Schedules 2025 First Quarter Financial Results and Conference Call

SUNation Energy Schedules 2025 First Quarter Financial Results and Conference Call

RONKONKOMA, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or “the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced …

EverCommerce Announces First Quarter 2025 Financial Results

EverCommerce Announces First Quarter 2025 Financial Results

DENVER, May 08, 2025 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading service commerce platform, today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial …

Rumble Reports First Quarter 2025 Results

Rumble Reports First Quarter 2025 Results

~ Revenue up 34% Year-over-Year to $23.7 Million ~ ~ Rumble Cloud Secures Contract with Government of El Salvador ~ ~ Significantly Improved MAU Retention Compared to 2022 Mid-Term Elections ~ ~ Tether Investment Completed, Balance Sheet Solidified ~ …

AvePoint Announces First Quarter 2025 Financial Results

AvePoint Announces First Quarter 2025 Financial Results

First quarter SaaS revenue of $68.9 million, representing 34% year-over-year growth, 37% on a constant currency basis First quarter Total revenue of $93.1 million, representing 25% year-over-year growth, 27% on a constant currency basis Total ARR of $345.5 …

Fulcrum Therapeutics to Participate in Upcoming May Conferences

Fulcrum Therapeutics to Participate in Upcoming May Conferences

CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …

Cytek Biosciences Reports First Quarter 2025 Financial Results

Cytek Biosciences Reports First Quarter 2025 Financial Results

FREMONT, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the first quarter ended March 31, 2025. First …

Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates

Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates

Presented positive 4- and 12-week clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome immune recognition, while continuing to function and persist with …

IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance

IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance

Quarterly revenue grew 11% versus prior year quarter - highest growth in ten quarters Adjusted EPS of $0.82 - an increase of 18% to prior year quarter Makes strategic entry into India - launching with leading healthcare client Board authorizes a new $15 …

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Initiated dose expansion in Phase 1 CARDINAL trial of TERN-701 in 2L+ CML Additional safety and efficacy data including 6-month MMR expected in 4Q25 Phase 2 FALCON trial of TERN-601 for obesity is enrolling well with top-line 12-week weight loss data …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service